Clinical trial
Evaluation of Anti-cancer Drugs Sensitivity on Fresh Samples From Healthy Patients and Patients With Myeloproliferative or Lymphoproliferative Disorders
NCT05001386 is registered in ClinicalTrials.gov with Hospices Civils de Lyon as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluation of Anti-cancer Drugs Sensitivity on Fresh Samples From Healthy Patients and Patients With Myeloproliferative or Lymphoproliferative Disorders
- Lead sponsor
- Hospices Civils de Lyon
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- March 31, 2022
- Completion date
- March 31, 2025
- Enrollment
- 800 (estimated)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.